Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BioPlus ApS
APS
Bankrupt
CVR 37630683
Kajakvej 2
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2016
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2019
DKK -112K
-156% vs 2018
EBITDA margin
100.0%
-169% vs 2018
Equity ratio
62.4%
Financial strength
Net profit 2019
DKK -118K
-193% vs 2018
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2017
0M
0%
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
DKK -112K
-156%
EBITDA
DKK -112K
-169%
Net profit
DKK -118K
-193%
Total assets
DKK 95K
-55%
Equity
DKK 59K
-66%
Employees
—
—
Company information
Legal name
BioPlus ApS
CVR number
37630683
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
15. april 2016
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2019-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Kajakvej 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in Tårnby
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
Income statement
DKK thousands
Item
2017
2018
2019
Revenue
10
200
-112
Staff expenses
-0
-0
-0
EBITDA
2
162
-112
Depreciation & amort.
-0
-0
-0
EBIT
2
162
-112
Net financials
-0
-0
0
Profit before tax
1
162
-112
Tax
0
36
6
Net profit
1
126
-118
Balance sheet
DKK thousands
Item
2017
2018
2019
Total assets
70
213
95
Equity
51
177
59
Long-term debt
0
0
0
Short-term debt
19
36
36
Total debt
19
36
36
Financial ratios
5-year trend
EBITDA margin
-11240900.0%
This company
15.8%
Market median
-71145037% vs market
2017
2019
Equity ratio
62.4%
This company
38.2%
Market median
+63% vs market
2017
2019
Return on equity
-198.1%
This company
18.4%
Market median
-1177% vs market
2017
2019
Net profit margin
-11768100.0%
This company
8.1%
Market median
-145285285% vs market
2017
2019
Asset turnover
-1.18×
This company
1.12×
Market median
-205% vs market
2017
2019
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
2017
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-04-15 – 2017-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
IA
Irini Angelidaki
Board of Directors
2016 – 2016
MA
Merlin Alvarado Morales
Board of Directors
2016 – 2016
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ioannis Fotidis
Individual
20–24.99%
20–24.99%
2016
Strimion Holding IVS
Company
20–24.99%
20–24.99%
2016
Biotech Pro ApS
Company
66.67–89.99%
66.67–89.99%
2016
SMARTKEEPER HOLDING ApS
Company
10–14.99%
10–14.99%
2016
Carsten Jensen
Individual
10–14.99%
10–14.99%
2016
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BioPlus ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Irini Angelidaki
Board of Directors
0 companies
Merlin Alvarado Morales
Board of Directors
0 companies